Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Albright

Showing results (431-440 of 441) with videos related to

Pageof 45
Sort By:
Neurosurgical Focus|August 22, 2006
Incidence and management of subdural hematoma/hygroma with variable- and fixed-pressure differential valves: a randomized, controlled study of programmable compared with conventional valvesP W Carmel, A L Albright, P D Adelson, et al.
Journal of the American Chemical Society|January 22, 2025
Impact of Ligand Structure on Biological Activity and Photophysical Properties of NHC-Protected Au<sub>13</sub> NanoclustersViveka K Kulkarni, Emily L Albright, Elham Zeinizade, et al.
International Quarterly of Community Health Education|September 16, 2010
A program to reduce cardiovascular and cerebrovascular disease in the czech republic: design and methods of the healthy dubec projectC L Albright, J W Farquhar, R Havel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 2, 2017
Contextual Impact of Neighborhood Obesogenic Factors on Postmenopausal Breast Cancer: The Multiethnic CohortShannon M Conroy, Christina A Clarke, Juan Yang, et al.
BMC Pregnancy and Childbirth|January 16, 2014
A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) studyAssiamira Ferrara, Monique M Hedderson, Cheryl L Albright, et al.
Journal of Neurosurgery|April 3, 1998
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupP L Robertson, P M Zeltzer, J M Boyett, et al.
JACS Au|May 13, 2022
NHC-Stabilized Au<sub>10</sub> Nanoclusters and Their Conversion to Au<sub>25</sub> NanoclustersPaul A Lummis, Kimberly M Osten, Tetyana I Levchenko, et al.
Diabetes Care|December 15, 2015
The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled TrialAssiamira Ferrara, Monique M Hedderson, Susan D Brown, et al.
Pediatric Neurosurgery|January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group StudyM Deutsch, P R Thomas, J Krischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III studyP M Zeltzer, J M Boyett, J L Finlay, et al.
Pageof 45

Showing results (431-440 of 441) with videos related to

Sort By:
Pageof 45
Neurosurgical Focus|August 22, 2006
Incidence and management of subdural hematoma/hygroma with variable- and fixed-pressure differential valves: a randomized, controlled study of programmable compared with conventional valvesP W Carmel, A L Albright, P D Adelson, et al.
Journal of the American Chemical Society|January 22, 2025
Impact of Ligand Structure on Biological Activity and Photophysical Properties of NHC-Protected Au<sub>13</sub> NanoclustersViveka K Kulkarni, Emily L Albright, Elham Zeinizade, et al.
International Quarterly of Community Health Education|September 16, 2010
A program to reduce cardiovascular and cerebrovascular disease in the czech republic: design and methods of the healthy dubec projectC L Albright, J W Farquhar, R Havel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 2, 2017
Contextual Impact of Neighborhood Obesogenic Factors on Postmenopausal Breast Cancer: The Multiethnic CohortShannon M Conroy, Christina A Clarke, Juan Yang, et al.
BMC Pregnancy and Childbirth|January 16, 2014
A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) studyAssiamira Ferrara, Monique M Hedderson, Cheryl L Albright, et al.
Journal of Neurosurgery|April 3, 1998
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupP L Robertson, P M Zeltzer, J M Boyett, et al.
JACS Au|May 13, 2022
NHC-Stabilized Au<sub>10</sub> Nanoclusters and Their Conversion to Au<sub>25</sub> NanoclustersPaul A Lummis, Kimberly M Osten, Tetyana I Levchenko, et al.
Diabetes Care|December 15, 2015
The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled TrialAssiamira Ferrara, Monique M Hedderson, Susan D Brown, et al.
Pediatric Neurosurgery|January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group StudyM Deutsch, P R Thomas, J Krischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III studyP M Zeltzer, J M Boyett, J L Finlay, et al.
Pageof 45